Real-World Survival in Patients with Metastatic Melanoma after Discontinuation of Anti-PD-1 Immunotherapy for Objective Response or Adverse Effects: A Retrospective Study

OBJECTIVE: Anti-PD-1 has dramatically improved the survival of patients with advanced melanoma. However, there is a lack of data on maintenance of the response after treatment discontinuation. We aimed to evaluate the progression-free survival (PFS) of patients with metastatic melanoma after anti-PD...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Oncol
Auteurs principaux: Valentin, Julie, Ferté, Thomas, Dorizy-Vuong, Valérie, Dousset, Léa, Prey, Sorilla, Dutriaux, Caroline, Pham-Ledard, Anne, Beylot-Barry, Marie, Gérard, Emilie
Format: Artigo
Langue:Inglês
Publié: Hindawi 2021
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8096591/
https://ncbi.nlm.nih.gov/pubmed/33995528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/5524685
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires